PATENT CLAIM ANALYSIS

Application Number: 15742093
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "04400A"]

Abstract:
Aspects of the invention relate to methods for treating ALS comprising administering to a subject in need thereof a therapeutically effective amount of a nucleic acid molecule that is directed against a gene encoding superoxide dismutase 1 (SOD1).

Claim (Index 5):
The isolated double stranded nucleic acid molecule of any one of  claims 1  to  4 , wherein a plurality of the U's and/or C's include a hydrophobic modification, selected from the group consisting of methyl, isobutyl, octyl, imidazole or thiophene and wherein the modifications are located on positions 4 or 5 of U's and/or C's.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 86.0
- Lexical Diversity: 1.13889
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13636755', '13636728', '14729006', '15099481', '14728653']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8730336064328096
- 35 USC 102 Novelty (BERT): 0.6320393312905292
- Combined Prediction Score: 0.8489341789185816
- Mean Citation Score: 498.6139359999999
- Max Citation Score: 534.2475
- Similarity Product: 445.494456102848

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test